Skip to main content

Cogent Biosciences, Inc.

COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001622229

In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in Cogent Biosciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
135
+1 vs. Q3 2022
Shares held
74.9M
+480.4K (+0.6%) vs. Q3 2022
Total value
$864.1M
−$239.0M (−21.7%) vs. Q3 2022
New holders
22
53 more added
Sold out
21
37 more reduced

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting COGT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 135 institutions
Q1 2021: 69 institutionsQ2 2021: 69 institutionsQ3 2021: 73 institutionsQ4 2021: 82 institutionsQ1 2022: 86 institutionsQ2 2022: 112 institutionsQ3 2022: 134 institutionsQ4 2022: 135 institutionsQ1 2023: 137 institutionsQ2 2023: 136 institutionsQ3 2023: 135 institutionsQ4 2023: 144 institutionsQ1 2024: 146 institutionsQ2 2024: 149 institutionsQ3 2024: 161 institutionsQ4 2024: 177 institutionsQ1 2025: 186 institutionsQ2 2025: 181 institutionsQ3 2025: 195 institutionsQ4 2025: 267 institutionsQ1 2026: 305 institutionsQ2 2026: 322 institutions
Value heldQ4 2022: $864.1M
Q1 2021: $303.3MQ2 2021: $293.7MQ3 2021: $309.6MQ4 2021: $385.2MQ1 2022: $353.6MQ2 2022: $633.3MQ3 2022: $1.10BQ4 2022: $864.1MQ1 2023: $810.4MQ2 2023: $1.05BQ3 2023: $885.8MQ4 2023: $534.0MQ1 2024: $734.3MQ2 2024: $1.02BQ3 2024: $1.32BQ4 2024: $949.5MQ1 2025: $799.6MQ2 2025: $973.2MQ3 2025: $2.29BQ4 2025: $6.18BQ1 2026: $7.17BQ2 2026: $7.50B
Institutions holding COGT and their total value by quarter
QuarterHoldersValue
Q2 2026322$7.50B
Q1 2026305$7.17B
Q4 2025267$6.18B
Q3 2025195$2.29B
Q2 2025181$973.2M
Q1 2025186$799.6M
Q4 2024177$949.5M
Q3 2024161$1.32B
Q2 2024149$1.02B
Q1 2024146$734.3M
Q4 2023144$534.0M
Q3 2023135$885.8M
Q2 2023136$1.05B
Q1 2023137$810.4M
Q4 2022135$864.1M
Q3 2022134$1.10B
Q2 2022112$633.3M
Q1 202286$353.6M
Q4 202182$385.2M
Q3 202173$309.6M
Q2 202169$293.7M
Q1 202169$303.3M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Cogent Biosciences, Inc.; share changes are against Q3 2022.

Institutions holding COGT in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Morgan Stanley491,437$5.68M0.00%−73,682−13.0%Reduced
New Leaf Venture Partners, L.L.C.501,530$5.80M4.20%00.0%Unchanged
Platinum Investment Management Ltd511,390$5.91M0.23%00.0%Unchanged
Boxer Capital, LLC525,000$6.07M0.33%+100,000+23.5%Added
Northern Trust Corp542,735$6.27M0.00%+7,132+1.3%Added
Goldman Sachs Group Inc645,737$7.46M0.00%−96,251−13.0%Reduced
Assenagon Asset Management S.A.698,271$8.07M0.03%−290,365−29.4%Reduced
D. E. Shaw & Co., Inc.733,460$8.48M0.01%−166,613−18.5%Reduced
5AM Venture Management, LLC790,440$9.14M2.46%00.0%Unchanged
Kynam Capital Management, LP794,049$9.18M1.41%−191,106−19.4%Reduced
Ghost Tree Capital, LLC800,000$9.25M3.95%+200,000+33.3%Added
Cormorant Asset Management, LP900,000$10.4M0.70%−550,000−37.9%Reduced
BVF Inc984,824$11.4M0.48%−1,100,000−52.8%Reduced
Candriam Luxembourg S.C.A.997,141$11.5M0.08%−154,361−13.4%Reduced
Adage Capital Partners GP, L.L.C.1,036,613$12.0M0.03%−110,037−9.6%Reduced
Logos Global Management LP1,100,000$12.7M1.49%+1,100,000New
FMR LLC1,141,491$13.2M0.00%−157,552−12.1%Reduced
Geode Capital Management, LLC1,222,330$14.1M0.00%+47,570+4.0%Added
Marshall Wace, LLP1,480,658$17.1M0.04%+1,480,658New
Janus Henderson Group PLC1,602,197$18.5M0.01%−86,332−5.1%Reduced
Suvretta Capital Management, LLC1,811,396$20.9M0.88%−51,204−2.7%Reduced
Citadel Advisors LLC1,854,320$21.4M0.02%+522,040+39.2%Added
Vivo Capital, LLC1,994,941$23.1M2.79%+111,000+5.9%Added
Frazier Life Sciences Management, L.P.2,109,154$24.4M1.52%+35,000+1.7%Added
Eventide Asset Management, LLC2,589,778$29.9M0.59%−271,114−9.5%Reduced
Fairmount Funds Management LLC2,758,975$31.9M5.06%00.0%Unchanged
Deerfield Management Company, L.P. (Series C)2,966,345$34.3M0.71%00.0%Unchanged
Perceptive Advisors LLC3,207,441$37.1M1.07%00.0%Unchanged
Vanguard Group Inc3,465,792$40.1M0.00%+282,022+8.9%Added
TCG Crossover Management, LLC3,631,042$42.0M7.41%+150,000+4.3%Added
VR Adviser, LLC4,038,117$46.7M7.86%00.0%Unchanged
State Street Corp4,261,381$49.3M0.00%+852,779+25.0%Added
Commodore Capital LP4,319,940$49.9M7.53%00.0%Unchanged
BlackRock Inc.4,946,443$57.2M0.00%+350,140+7.6%Added
Ra Capital Management, L.P.5,999,481$69.4M1.41%+1,986,028+49.5%Added
Avidity Partners Management LP0$00.00%−1,357,700−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−1,049,542−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−357,200−100.0%Sold out
EAM Investors, LLC0$00.00%−337,777−100.0%Sold out
Voloridge Investment Management, LLC0$00.00%−288,567−100.0%Sold out
AXA S.A.0$00.00%−285,210−100.0%Sold out
Ally Bridge Group (NY) LLC0$00.00%−204,014−100.0%Sold out
BNP Paribas Arbitrage, SA0$00.00%−175,767−100.0%Sold out
EAM Global Investors LLC0$00.00%−122,938−100.0%Sold out
Alpha Paradigm Partners, LLC0$00.00%−76,348−100.0%Sold out
Woodline Partners LP0$00.00%−69,871−100.0%Sold out
SEI Investments Co0$00.00%−37,810−100.0%Sold out
Fred Alger Management, LLC0$00.00%−31,409−100.0%Sold out
Jane Street Group, LLC0$00.00%−28,506−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−19,752−100.0%Sold out
Fox Run Management, L.L.C.0$00.00%−18,621−100.0%Sold out
Renaissance Technologies LLC0$00.00%−15,168−100.0%Sold out
Wells Fargo & Company0$00.00%−1,702−100.0%Sold out
High Net Worth Advisory Group LLC0$00.00%−1,500−100.0%Sold out
Ellevest, Inc.0$00.00%−7−100.0%Sold out
Parallel Advisors, LLC0$00.00%−8−100.0%Sold out